邓静瑜,王攀,陈雨诺,奚广军

• 1:南京医科大学附属无锡人民医院神经内科

摘要(Abstract)：

缺血性脑卒中具有高发病率、高致残率的特点。最新研究表明肠道菌群代谢产物氧化三甲胺（trimethylamine-N-oxide,TMAO）可促进动脉粥样硬化的发生、发展，提高血小板的反应性，增加血栓形成的风险。本文对TMAO在缺血性脑卒中的研究进展进行综述。

关键词(KeyWords)： 缺血性卒中;肠道菌群代谢产物;氧化三甲胺

Abstract:

Keywords:

基金项目(Foundation): 江苏省青年医学重点人才基金（GSK3β/β-catenin和糖皮质激素介导REDD1-m TORC1信号通路的交互作用与抗抑郁治疗快速起效分子机制研究,No.QNRC2016191）;; 无锡市“双百”医疗卫生中青年后备拔尖人才（GSK3B对谷氨酸递质系统的调节在抗抑郁治疗快速起效中的作用研究,No.HB2020016）

作者(Author): 邓静瑜,王攀,陈雨诺,奚广军

DOI: 10.16780/j.cnki.sjssgncj.20250028

参考文献(References)：

• [1]《中国脑卒中防治报告2021》概要[J].中国脑血管病杂志, 2023, 20(11):783-793.
• [2] Jaworska K, Kopacz W, Koper M, et al. Microbiome-Derived Trimethylamine N-Oxide(TMAO)as a Multifaceted Biomarker in Cardiovascular Disease:Challenges and Opportunities[J]. Int J Mol Sci,2024, 25(23):12511.
• [3] Li Z, He X, Fang Q, et al. Gut Microbe-Generated Metabolite Trimethylamine-N-Oxide and Ischemic Stroke[J]. Biomolecules, 2024, 14(11):1463.
• [4] Xie G, Yan A, Lin P, et al. Trimethylamine N-oxide-a marker for atherosclerotic vascular disease[J]. Rev Cardiovasc Med, 2021, 22(3):787-797.
• [5] M?ynarska E, Wasiak J, Gajewska A, et al. Gut Microbiota and Gut-Brain Axis in Hypertension:Implications for Kidney and Cardiovascular Health-A Narrative Review[J]. Nutrients, 2024, 16(23):4079.
• [6] Yang T, Santisteban MM, Rodriguez V, et al. Gut dysbiosis is linked to hypertension[J]. Hypertension, 2015, 65(6):1331-1340.
• [7] Ufnal M, Jazwiec R, Dadlez M, et al. Trimethylamine-N-oxide:a carnitine-derived metabolite that prolongs the hypertensive effect of angiotensin II in rats[J]. Can J Cardiol, 2014, 30(12):1700-1705.
• [8] Jaworska K, Huc T, Samborowska E, et al. Hypertension in rats is associated with an increased permeability of the colon to TMA, a gut bacteria metabolite[J]. PLoS One, 2017, 12(12):e0189310.
• [9] Liu M, Han Q, Yang J. Trimethylamine-N-oxide(TMAO)increased aquaporin-2 expression in spontaneously hypertensive rats[J]. Clin Exp Hypertens, 2019, 41(4):312-322.
• [10] Ge X, Zheng L, Zhuang R, et al. The Gut Microbial Metabolite Trimethylamine N-Oxide and Hypertension Risk:A Systematic Review and Dose-Response Meta-analysis[J]. Adv Nutr, 2020, 11(1):66-76.
• [11] Nie J, Xie L, Zhao B X, et al. Serum Trimethylamine N-Oxide Concentration Is Positively Associated With First Stroke in Hypertensive Patients[J]. Stroke, 2018, 49(9):2021-2028.
• [12] Wang H, Luo Q, Ding X, et al. Trimethylamine N-oxide and its precursors in relation to blood pressure:A mendelian randomization study[J]. Front Cardiovasc Med, 2022, 9:922441.
• [13] Guraka A, Sreedharan S, Arasaradnam R, et al. The Role of the Gut Microbiome in the Development and Progression of Type 2 Diabetes and Liver Disease[J]. Nutr Rev, 2024:nuae172.
• [14] Chen K, Wang H, Yang X, et al. Targeting gut microbiota as a therapeutic target in T2DM:A review of multi-target interactions of probiotics, prebiotics, postbiotics, and synbiotics with the intestinal barrier[J]. Pharmacol Res, 2024, 210:107483.
• [15] Sircana A, Framarin L, Leone N, et al. Altered Gut Microbiota in Type 2 Diabetes:Just a Coincidence[J]? Curr Diab Rep, 2018, 18(10):98.
• [16] Upadhyaya S, Banerjee G. Type 2 diabetes and gut microbiome:at the intersection of known and unknown[J]. Gut Microbes, 2015, 6(2):85-92.
• [17] Dambrova M, Latkovskis G, Kuka J, et al. Diabetes is Associated with Higher Trimethylamine N-oxide Plasma Levels[J]. Exp Clin Endocrinol Diabetes, 2016, 124(4):251-256.
• [18] Govindarajulu M, Pinky P D, Steinke I, et al. Gut Metabolite TMAO Induces Synaptic Plasticity Deficits by Promoting Endoplasmic Reticulum Stress[J]. Front Mol Neurosci, 2020, 13:138.
• [19] Miao J, Ling A V, Manthena P V, et al. Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis[J]. Nat Commun, 2015, 6:6498.
• [20] Li X, Chen Y, Liu J, et al. Serum metabolic variables associated with impaired glucose tolerance induced by high-fat-high-cholesterol diet in Macaca mulatta[J]. Exp Biol Med(Maywood), 2012, 237(11):1310-1321.
• [21] Shan Z, Sun T, Huang H, et al. Association between microbiota-dependent metabolite trimethylamine-N-oxide and type 2diabetes[J]. Am J Clin Nutr, 2017, 106(3):888-894.
• [22] Tang WH, Wang Z, Li XS, et al. Increased Trimethylamine N-Oxide Portends High Mortality Risk Independent of Glycemic Control in Patients with Type 2 Diabetes Mellitus[J]. Clin Chem, 2017, 63(1):297-306.
• [23] Gao X, Liu X, Xu J, et al. Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet[J]. J Biosci Bioeng, 2014, 118(4):476-481.
• [24] Kong L, Zhao Q, Jiang X, et al. Trimethylamine N-oxide impairsβ-cell function and glucose tolerance[J]. Nat Commun, 2024, 15(1):2526.
• [25] Koeth RA, Wang Z, Levison BS, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis[J]. Nat Med, 2013, 19(5):576-585.
• [26] Ding L, Chang M, Guo Y, et al. Trimethylamine-N-oxide(TMAO)-induced atherosclerosis is associated with bile acid metabolism[J]. Lipids Health Dis, 2018, 17(1):286.
• [27] Xiong X, Zhou J, Fu Q, et al. The associations between TMAO-related metabolites and blood lipids and the potential impact of rosuvastatin therapy[J]. Lipids Health Dis, 2022, 21(1):60.
• [28] Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease[J]. Nature, 2011, 472(7341):57-63.
• [29] Geng J, Yang C, Wang B, et al. Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK/JNK pathway[J]. Biomed Pharmacother, 2018, 97:941-947.
• [30] Wang Z, Roberts AB, Buffa JA, et al. Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis[J]. Cell, 2015, 163(7):1585-1595.
• [31] Zhu W, Gregory JC, Org E, et al. Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk[J]. Cell, 2016, 165(1):111-124.
• [32] Zhu W, Buffa J A, Wang Z, et al. Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk[J]. J Thromb Haemost, 2018, 16(9):1857-1872.
• [33] Roberts AB, Gu X, Buffa JA, et al. Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potential[J].Nat Med, 2018, 24(9):1407-1417.
• [34] Zhu W, Wang Z, Tang W, et al. Gut Microbe-Generated Trimethylamine N-Oxide From Dietary Choline Is Prothrombotic in Subjects[J]. Circulation, 2017, 135(17):1671-1673.
• [35] Li Z, He X, Fang Q, et al. Gut Microbe-Generated Metabolite Trimethylamine-N-Oxide and Ischemic Stroke[J]. Biomolecules, 2024,14(11):1463.
• [36] Schneider C, Okun JG, Schwarz KV, et al. Trimethylamine-N-oxide is elevated in the acute phase after ischaemic stroke and decreases within the first days[J]. Eur J Neurol, 2020, 27(8):1596-1603.
• [37] Sun T, Zhang Y, Yin J, et al. Association of Gut Microbiota-Dependent Metabolite Trimethylamine N-Oxide with First Ischemic Stroke[J]. J Atheroscler Thromb, 2021, 28(4):320-328.
• [38] Rexidamu M, Li H, Jin H, et al. Serum levels of Trimethylamine-N-oxide in patients with ischemic stroke[J]. Biosci Rep,2019, 39(6):BSR20190515.
• [39] Lemaitre RN, Jensen PN, Wang Z, et al. Plasma Trimethylamine-N-Oxide and Incident Ischemic Stroke:The Cardiovascular Health Study and the Multi-Ethnic Study of Atherosclerosis[J]. J Am Heart Assoc, 2023, 12(16):e8711.
• [40] Wu C, Li C, Zhao W, et al. Elevated trimethylamine N-oxide related to ischemic brain lesions after carotid artery stenting[J]. Neurology, 2018,90(15):e1283-e1290.
• [41] Wu C, Xue F, Lian Y, et al. Relationship between elevated plasma trimethylamine N-oxide levels and increased stroke injury[J]. Neurology,2020, 94(7):e667-e677.
• [42] Li Z, Hui J, Li S, et al. Trimethylamine N-oxide predicts stroke severity in diabetic patients with acute ischaemic stroke and is related to glycemic variability[J]. Eur J Neurol, 2023, 30(11):3478-3486.
• [43]惠姣洁,王枫,毛旭强,等.肠道菌群代谢产物氧化三甲胺对糖尿病急性缺血性卒中早期神经功能恶化的影响[J].中华老年医学杂志,2023, 42(7):794-798.
• [44] Hou L, Zhang Y, Zheng D, et al. Increasing trimethylamine N-oxide levels as a predictor of early neurological deterioration in patients with acute ischemic stroke[J]. Neurol Res, 2020, 42(2):153-158.
• [45] Zhu W, Romano KA, Li L, et al. Gut microbes impact stroke severity via the trimethylamine N-oxide pathway[J]. Cell Host Microbe, 2021, 29(7):1199-1208.
• [46] Chen Y, Xu J, Pan Y, et al. Association of Trimethylamine N-Oxide and Its Precursor With Cerebral Small Vessel Imaging Markers[J]. Front Neurol, 2021, 12:648702.
• [47] Kijpaisalratana N, Ament Z, Bevers M B, et al. Trimethylamine N-Oxide and White Matter Hyperintensity Volume Among Patients With Acute Ischemic Stroke[J]. JAMA Netw Open, 2023, 6(8):e2330446.